SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences Group is currently the top trending ticker as investors debate the impact of trial protocol modifications on its REGAL Phase 3 study and upcoming AACR presentation. While some community members highlight potential long-term clinical efficacy and a possible buyout, others express strong skepticism regarding the trial's design and management's transparency.

Maulcoin

Maulcoin is trending as its community actively rallies to defend the project's organic growth and transparency against perceived market manipulation and copycat tokens. Supporters are heavily focused on coordinating buying challenges to build a stronger price floor and establish the coin as a legitimate, community-led project.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

The 401jK community is actively promoting its meme-centric narrative as a defiant alternative to traditional, broken retirement systems. Investors are debating the project's long-term utility versus its high volatility, while the community continues to focus on grassroots educational initiatives and widespread IRL marketing.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

Investors are rallying behind $RETIRE as a tokenized alternative to traditional retirement plans, positioning it as a movement against the established financial system. The community is actively building momentum through weekly dollar-cost averaging and frequent social media campaigns, driven by hopes for significant long-term growth and financial independence.

Daddy Darth Sidious

Investors are fueling speculation around SIDIOUS and DARTH, with the community actively debating whether a sector-wide rotation away from rival tokens is underway. Discussions are centered on potential momentum plays as participants urge others to buy the dip while navigating concerns over market volatility and project sustainability.

Daddy Darth Vader

DARTH is currently driving intense community speculation amid a "daddy war" rivalry with $MAULCOIN, with participants actively debating the token's long-term viability versus its nature as a high-risk trading opportunity. While some investors focus on liquidity building and potential parabolic gains, others express strong skepticism, labeling the project a potential scam or pump-and-dump scheme.

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Bicycle Therapeutics Plc - ADR

Bicycle Therapeutics is trending as investors focus on upcoming clinical data from the AACR conference, particularly concerning its lead asset BT5528 in combination studies. While community sentiment is divided between optimism regarding its strong cash runway and the potential of its radiopharma pivot versus concerns over past regulatory hurdles and pipeline restructuring, the stock remains a high-interest subject for those weighing binary biotech risk against a solid balance sheet.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is generating significant community discourse as participants debate the impact of the LitVM testnet launch and the asset's historical performance relative to the broader crypto market. Investors are actively watching critical support and resistance levels while weighing long-term conviction in the project's utility against frustration over recent price consolidation and the lack of substantial institutional inflows.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending as investors monitor the anticipation of the April 30, 2026, PDUFA date for AXS-05, a pivotal regulatory catalyst for Alzheimer's disease-associated agitation. The community is actively discussing the company's aggressive expansion of its sales force and strong prescription growth for Auvelity, while analysts continue to adjust price targets upward in response to high conviction in the drug's approval prospects.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is gaining significant market attention as investors highlight its strategic partnerships with NVIDIA and its development of quantum sensing technology for defense and space applications. The community is actively discussing the stock's potential for a valuation re-rating, often comparing its current market cap to other quantum sector peers while noting its recent inclusion in high-profile quantum AI initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sidoti Issues Pessimistic Forecast for Daktronics Earnings

Daktronics, Inc. (NASDAQ:DAKT - Free Report) - Equities researchers at Sidoti lowered their Q4 2026 EPS estimates for shares of Daktronics in a report issued on Tuesday, April 14th. Sidoti analyst A. Soderstrom now expects that the technology company will earn $0.16 per share for the quarter, down f...

What is Sidoti's Estimate for Daktronics FY2026 Earnings?

Daktronics, Inc. (NASDAQ:DAKT - Free Report) - Equities researchers at Sidoti lowered their FY2026 EPS estimates for Daktronics in a research note issued to investors on Tuesday, April 14th. Sidoti...

Daktronics, Inc. $DAKT Position Reduced by SG Americas Securities LLC

SG Americas Securities LLC trimmed its stake in shares of Daktronics, Inc. (NASDAQ:DAKT - Free Report) by 72.0% during the fourth quarter, according to its most recent filing with the Securities and...

Daktronics Investor Day: Reaffirms 7%-10% CAGR Targets, Eyes Higher-Margin Software & Services

Daktronics (NASDAQ:DAKT) used its 2026 Investor Day to outline a multi-year plan focused on accelerating profitable growth, expanding software and services, and improving manufacturing efficiency...

Daktronics, Inc. (NASDAQ:DAKT) Short Interest Up 22.2% in March

Daktronics, Inc. (NASDAQ:DAKT - Get Free Report) was the target of a large increase in short interest in the month of March. As of March 13th, there was short interest totaling 1,531,741 shares, an increase of 22.2% from the February 26th total of 1,253,531 shares. Based on an average daily...

CSM Advisors LLC Has $7.07 Million Stock Holdings in Daktronics, Inc. $DAKT

CSM Advisors LLC trimmed its holdings in Daktronics, Inc. (NASDAQ:DAKT - Free Report) by 18.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange...

Sidoti Comments on Daktronics' FY2026 Earnings (NASDAQ:DAKT)

Daktronics, Inc. (NASDAQ:DAKT - Free Report) - Sidoti dropped their FY2026 earnings per share estimates for shares of Daktronics in a research report issued to clients and investors on Thursday...

Vanguard Group Inc. Sells 302,393 Shares of Daktronics, Inc. $DAKT

Vanguard Group Inc. reduced its stake in Daktronics, Inc. (NASDAQ:DAKT - Free Report) by 8.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned...

Sidoti Has Bullish Forecast for Daktronics FY2027 Earnings

Daktronics, Inc. (NASDAQ:DAKT - Free Report) - Stock analysts at Sidoti increased their FY2027 earnings estimates for Daktronics in a research report issued to clients and investors on Thursday...

Daktronics Q3 Earnings Call Highlights

Daktronics (NASDAQ:DAKT) reported third-quarter fiscal 2026 results highlighted by double-digit revenue growth, continued strong order activity above $200 million, and a rising backlog as the company...

Daktronics, Inc. engages in designing and manufacturing electronic scoreboards, programmable display systems and large screen video displays for sporting, commercial and transportation applications. It operates through the following segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The Commercial segment sells video, display systems, digital billboards, Galaxy, and Fuelight product lines to resellers, out-of-home companies, national retailers, quick-serve restaurants, casinos, shopping centers, cruise ships, commercial building owners, and petroleum retailers. The Live Events segment provides scoring and video display systems to college and professional sports facilities and convention centers and the sale of mobile display technology to video rental organizations and other live events type venues. The High School Park and Recreation segment engages in the sale of scoring systems, Galaxy displays, and video display systems to primary and secondary education facilities. The Transportation segment consists of sales of Vanguard and Galaxy product lines to governmental transportation departments, airlines, and other transportation related customers. The International segment is composed of sales of all product lines outside the United States and Canada. The company was founded by Aelred J. Kurtenbach and Duane E. Sander in 1968 and is headquartered in Brookings, SD.

Current Price	$19.67
Prev Close	$19.07
Open	$19.34
Dividend Yield	0.00%
50-Day Moving Average	$22.56
Beta	1.25
Avg. Volume	679,688.49
PE Ratio	35.39

52-Week High	$28.27
52-Week Low	$11.97
Market Capitalization	$921.04M
EPS (Annual)	-$0.2127
Price to Book	3.23
Revenue Per Employee	$279,969.28

DAKT
Daktronics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DAKT News

DAKTDaktronics Inc.